U.S. patent number D760,374 [Application Number D/440,941] was granted by the patent office on 2016-06-28 for drug delivery system.
This patent grant is currently assigned to INSULINE MEDICAL LTD.. The grantee listed for this patent is Insuline Medical Ltd. Invention is credited to Elisha Amir, Gadi Amit, Gabriel Bitton, Ron Nagar, Barbara A. Stettler, Brandon Warren.
United States Patent |
D760,374 |
Nagar , et al. |
June 28, 2016 |
Drug delivery system
Claims
CLAIM We claim the ornamental design for a drug delivery system, as
shown and described.
Inventors: |
Nagar; Ron (Petach-Tikva,
IL), Bitton; Gabriel (Jerusalem, IL), Amir;
Elisha (Livnim, IL), Amit; Gadi (San Mateo,
CA), Stettler; Barbara A. (Oakland, CA), Warren;
Brandon (San Francisco, CA) |
Applicant: |
Name |
City |
State |
Country |
Type |
Insuline Medical Ltd |
Petach-Tikva |
N/A |
IL |
|
|
Assignee: |
INSULINE MEDICAL LTD.
(Petach-Tikva, IL)
|
Appl.
No.: |
D/440,941 |
Filed: |
December 28, 2012 |
Current U.S.
Class: |
D24/108 |
Current International
Class: |
2401 |
Field of
Search: |
;D24/107,108,111-113,127,128 ;604/67,181,184,187,151,180 |
References Cited
[Referenced By]
U.S. Patent Documents
Foreign Patent Documents
|
|
|
|
|
|
|
WO 2012153295 |
|
Nov 2012 |
|
WO |
|
Primary Examiner: Pratt; Deanna L
Assistant Examiner: Bekic; Lilyana
Attorney, Agent or Firm: Cooley LLP
Description
FIG. 1 is a perspective view of a control unit in a drug delivery
system;
FIG. 2 is a side view of the control unit in the drug delivery
system;
FIG. 3 is another side view of the control unit in the drug
delivery system;
FIG. 4 is a back side view of the control unit in the drug delivery
system;
FIG. 5 is a front side view of the control unit in the drug
delivery system;
FIG. 6 is a top view of the control unit in the drug delivery
system;
FIG. 7 is a bottom view of the control unit in the drug delivery
system;
FIG. 8 is a perspective view of the control unit being coupled to
an injection window in the drug delivery system;
FIG. 9 is a side view of the control unit being coupled to the
injection window in the drug delivery system;
FIG. 10 is another side view of the control unit being coupled to
the injection window in the drug delivery system;
FIG. 11 is a front view of the control unit being coupled to the
injection window in the drug delivery system;
FIG. 12 is a back view of the control unit being coupled to the
injection window in the drug delivery system;
FIG. 13 is a top view of the control unit being coupled to the
injection window in the drug delivery system;
FIG. 14 is a bottom view of the control unit being coupled to the
injection window in the drug delivery system;
FIG. 15 is an exploded perspective view of the control unit and the
injection window in the drug delivery system;
FIG. 16 is a perspective view of the control unit being coupled to
an injection window and an adhesive element in the drug delivery
system;
FIG. 17 is a side view of the control unit being coupled to the
injection window and the adhesive element in the drug delivery
system;
FIG. 18 is another side view of the control unit being coupled to
the injection window and the adhesive element in the drug delivery
system;
FIG. 19 is a front view of the control unit being coupled to the
injection window and the adhesive element in the drug delivery
system;
FIG. 20 is a back view of the control unit being coupled to the
injection window and the adhesive element in the drug delivery
system;
FIG. 21 is a top view of the control unit being coupled to the
injection window and the adhesive element in the drug delivery
system;
FIG. 22 is a bottom view of the control unit being coupled to the
injection window and the adhesive element in the drug delivery
system;
FIG. 23 is an exploded perspective view of the control unit and the
injection window and the adhesive element in the drug delivery
system;
FIG. 24 is a perspective view of the injection window in a folded
state in the drug delivery system;
FIG. 25 is a side view of the injection window in the folded state
in the drug delivery system;
FIG. 26 is another side view of the injection window in the folded
state in the drug delivery system;
FIG. 27 is a front view of the injection window in the folded state
in the drug delivery system;
FIG. 28 is a back view of the injection window in the folded state
in the drug delivery system;
FIG. 29 is a top view of the injection window in the folded state
in the drug delivery system;
FIG. 30 is a bottom view of the injection window in the folded
state in the drug delivery system;
FIG. 31 is a perspective view of the injection window in an
unfolded state in the drug delivery system;
FIG. 32 is a side view of the injection window in the unfolded
state in the drug delivery system;
FIG. 33 is another side view of the injection window in the
unfolded state in the drug delivery system;
FIG. 34 is a front view of the injection window in the unfolded
state in the drug delivery system;
FIG. 35 is a back view of the injection window in the unfolded
state in the drug delivery system;
FIG. 36 is a top view of the injection window in the unfolded state
in the drug delivery system;
FIG. 37 is a bottom view of the injection window in the unfolded
state in the drug delivery system;
FIG. 38 is a top and back perspective view of a charging element in
the drug delivery system;
FIG. 39 is a front view of the charging element in the drug
delivery system;
FIG. 40 is a back view of the charging element in the drug delivery
system;
FIG. 41 is a side view of the charging element in the drug delivery
system;
FIG. 42 is another side view of the charging element in the drug
delivery system;
FIG. 43 is a top view of the charging element in the drug delivery
system;
FIG. 44 is a bottom view of the charging element in the drug
delivery system; and,
FIG. 45 is a front perspective view of a charging element in the
drug delivery system.
The claimed design is directed to the collective appearance of the
control unit, injection window, adhesive element, and charging
element of the drug delivery system.
* * * * *